← Leaderboards
Evan Todd Keller
University Of Michigan At Ann Arbor
$23,141,123
Attributed
$23,141,123
Total exposure
25
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$54,872,854 · 27
By mechanism
P01$40,855,780 · 12
R01$7,280,004 · 6
U54$2,136,129 · 1
P30$1,625,576 · 4
P50$1,256,354 · 1
T32$1,117,424 · 1
Top collaborators
- Kenneth J. Pienta4 shared
- Yusuke Shiozawa4 shared
- Russell S Taichman4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Russell S Taichman$8,193,509
- Yusuke Shiozawa$3,431,923
- Gorav Ailawadi$4,825,522
- Martin G Sanda$22,920,886
- Laurence H Baker$13,775,401
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateMetastatic Neoplasm To The BoneBiologyBoneResearch PersonnelProgramsTumorCellsNeoplasm MetastasisServicesMalignant NeoplasmsAnimalsIn VivoPhenotypeAmericanResource SharingAnimal ModelProteinsGrowthEnsureNeoplastic CellResourcesImageCessation Of Life
Grant awards (118)
Single Cell Spatial Analysis$195,727
P30 · FY2025 · CA · contact PI
Shared Resource Management$177,283
P30 · FY2025 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,406,738
P01 · FY2024 · CA · contact PI
Core B - Animal Core$334,831
P01 · FY2024 · CA · contact PI
Core A - Administrative Core$213,789
P01 · FY2024 · CA · contact PI
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis$178,700
P01 · FY2024 · CA · contact PI
Shared Resource Management$170,518
P30 · FY2024 · CA · contact PI
Single Cell Spatial Analysis$161,756
P30 · FY2024 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,480,775
P01 · FY2023 · CA · contact PI
Core B - Animal Core$352,446
P01 · FY2023 · CA · contact PI
Core A - Administrative Core$225,035
P01 · FY2023 · CA · contact PI
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis$188,101
P01 · FY2023 · CA · contact PI
Shared Resource Management$174,236
P30 · FY2023 · CA · contact PI
Single Cell Spatial Analysis$168,453
P30 · FY2023 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,451,185
P01 · FY2022 · CA · contact PI
Core B - Animal Core$345,576
P01 · FY2022 · CA · contact PI
Core A - Administrative Core$220,650
P01 · FY2022 · CA · contact PI
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis$184,431
P01 · FY2022 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,480,743
P01 · FY2021 · CA · contact PI
Core B - Animal Core$352,232
P01 · FY2021 · CA · contact PI
Core A - Administrative Core$224,897
P01 · FY2021 · CA · contact PI
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis$187,982
P01 · FY2021 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,517,805
P01 · FY2020 · CA · contact PI
Core B - Animal Core$352,221
P01 · FY2020 · CA · contact PI
Core A - Administrative Core$224,893
P01 · FY2020 · CA · contact PI
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis$187,977
P01 · FY2020 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,465,446
P01 · FY2019 · CA · contact PI
Osteocytes in prostate cancer bone metastasis$343,925
R01 · FY2019 · CA · contact PI
Administrative Core$254,229
P01 · FY2019 · CA · contact PI
Tumor microvesicle-mediated modulation of the bone microenvironment$223,901
P01 · FY2019 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,510,770
P01 · FY2018 · CA · contact PI
Osteocytes in prostate cancer bone metastasis$354,563
R01 · FY2018 · CA · contact PI
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer$262,312
P50 · FY2018 · CA · contact PI
Administrative Core$262,090
P01 · FY2018 · CA · contact PI
Tumor microvesicle-mediated modulation of the bone microenvironment$230,827
P01 · FY2018 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,510,770
P01 · FY2017 · CA · contact PI
Osteocytes in prostate cancer bone metastasis$354,563
R01 · FY2017 · CA · contact PI
Administrative Core$334,899
P01 · FY2017 · CA · contact PI
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer$249,533
P50 · FY2017 · CA · contact PI
Tumor microvesicle-mediated modulation of the bone microenvironment$241,798
P01 · FY2017 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,510,770
P01 · FY2016 · CA · contact PI
Osteocytes in prostate cancer bone metastasis$354,563
R01 · FY2016 · CA · contact PI
Administrative Core$338,535
P01 · FY2016 · CA · contact PI
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer$246,637
P50 · FY2016 · CA · contact PI
Tumor microvesicle-mediated modulation of the bone microenvironment$235,093
P01 · FY2016 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,519,390
P01 · FY2015 · CA · contact PI
Animal Core$355,052
P01 · FY2015 · CA · contact PI
Osteocytes in prostate cancer bone metastasis$355,039
R01 · FY2015 · CA · contact PI
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib$249,853
P50 · FY2015 · CA · contact PI
Administrative Core$223,652
P01 · FY2015 · CA · contact PI
Tumor microvesicle-mediated modulation of the bone microenvironment$164,347
P01 · FY2015 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$495,498
U54 · FY2014 · CA
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib$248,019
P50 · FY2014 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,409,508
P01 · FY2013 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$487,171
U54 · FY2013 · CA
Animal Core$319,394
P01 · FY2013 · CA · contact PI
Microfluidic PCR System for Single Cell Transcriptional Analysis$241,690
S10 · FY2013 · OD · contact PI
DKK as a Key Regulator of Prostate Cancer Bone Metastasis$212,079
P01 · FY2013 · CA · contact PI
Administrative Core$135,855
P01 · FY2013 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,506,835
P01 · FY2012 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$612,460
U54 · FY2012 · CA
Animal Core$337,743
P01 · FY2012 · CA · contact PI
DKK as a Key Regulator of Prostate Cancer Bone Metastasis$227,142
P01 · FY2012 · CA · contact PI
Administrative Core$146,760
P01 · FY2012 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,514,414
P01 · FY2011 · CA · contact PI
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche$541,000
U54 · FY2011 · CA
Animal Core$335,790
P01 · FY2011 · CA · contact PI
DKK as a Key Regulator of Prostate Cancer Bone Metastasis$228,692
P01 · FY2011 · CA · contact PI
Administrative Core$148,993
P01 · FY2011 · CA · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,568,348
P01 · FY2010 · CA · contact PI
In vivo non-invasive 3D quantitative IVIS Spectrum molecular imaging system$359,897
S10 · FY2010 · RR · contact PI
Animal Core$346,513
P01 · FY2010 · CA · contact PI
DKK as a Key Regulator of Prostate Cancer Bone Metastasis$237,113
P01 · FY2010 · CA · contact PI
Administrative Core$154,275
P01 · FY2010 · CA · contact PI
Aging Rodent Core$93,382
P30 · FY2010 · AG · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,511,795
P01 · FY2009 · CA · contact PI
Animal Core$338,518
P01 · FY2009 · CA · contact PI
DKK as a Key Regulator of Prostate Cancer Bone Metastasis$231,641
P01 · FY2009 · CA · contact PI
Administrative Core$165,835
P01 · FY2009 · CA · contact PI
CORE--AGING TRANSGENIC RODENT/PATHOLOGY$125,980
P30 · FY2009 · AG · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,440,585
P01 · FY2008 · CA · contact PI
BMPs and prostate cancer skeletal metastases$246,720
P01 · FY2008 · CA · contact PI
Prostate Cancer Metastasis Suppressor: Role of RKIP$237,918
R01 · FY2008 · CA · contact PI
CORE--AGING TRANSGENIC RODENT/PATHOLOGY$131,441
P30 · FY2008 · AG · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,434,433
P01 · FY2007 · CA · contact PI
BMPs and prostate cancer skeletal metastases$244,654
P01 · FY2007 · CA · contact PI
Prostate Cancer Metastasis Suppressor: Role of RKIP$237,918
R01 · FY2007 · CA · contact PI
CORE--AGING TRANSGENIC RODENT/PATHOLOGY$109,061
P30 · FY2007 · AG · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,464,575
P01 · FY2006 · CA · contact PI
DEVELOPMENT OF MATURE ZEBRAFISH AS AN ANIMAL MODEL$368,131
R01 · FY2006 · AG · contact PI
Prostate Cancer Metastasis Suppressor: Role of RKIP$245,023
R01 · FY2006 · CA · contact PI
BMPs and prostate cancer skeletal metastases$139,021
P01 · FY2006 · CA · contact PI
CORE--AGING TRANSGENIC RODENT/PATHOLOGY$59,739
P30 · FY2006 · AG · contact PI
The Biology of Prostate Cancer Skeletal Metastases$1,433,998
P01 · FY2005 · CA
DEVELOPMENT OF MATURE ZEBRAFISH AS AN ANIMAL MODEL$376,480
R01 · FY2005 · AG
VEGF and bone remodeling in skeletal metastases$304,024
R01 · FY2005 · CA
Prostate Cancer Metastasis Suppressor: Role of RKIP$250,920
R01 · FY2005 · CA
BMPs and prostate cancer skeletal metastases$135,032
P01 · FY2005 · CA
CORE--AGING TRANSGENIC RODENT/PATHOLOGY$58,000
P30 · FY2005 · AG
The Biology of Prostate Cancer Skeletal Metastases$1,456,719
P01 · FY2004 · CA
DEVELOPMENT OF MATURE ZEBRAFISH AS AN ANIMAL MODEL$376,480
R01 · FY2004 · AG
VEGF and bone remodeling in skeletal metastases$304,024
R01 · FY2004 · CA
Prostate Cancer Metastasis Suppressor: Role of RKIP$250,920
R01 · FY2004 · CA
Administration Core$159,125
P01 · FY2004 · CA
BMPs and prostate cancer skeletal metastases$131,099
P01 · FY2004 · CA
DEVELOPMENT OF MATURE ZEBRAFISH AS AN ANIMAL MODEL$372,400
R01 · FY2003 · AG
VEGF and bone remodeling in skeletal metastases$304,024
R01 · FY2003 · CA
BIOMEDICAL RESEARCH TRAINING FOR VETERINARY SCIENTISTS$424,921
T32 · FY2002 · RR
DEVELOPMENT OF MATURE ZEBRAFISH AS AN ANIMAL MODEL$350,980
R01 · FY2002 · AG
AGING, GENE EXPRESSION AND OXIDATIVE STRESS$234,714
R01 · FY2002 · AG
ETHANOL MEDIATED OSTEOPOROSIS AND INTERLEUKIN 6$203,918
R01 · FY2002 · AG
BIOMEDICAL RESEARCH TRAINING FOR VETERINARY SCIENTISTS$366,537
T32 · FY2001 · RR
ETHANOL MEDIATED OSTEOPOROSIS AND INTERLEUKIN 6$255,063
R01 · FY2001 · AG
AGING, GENE EXPRESSION AND OXIDATIVE STRESS$228,239
R01 · FY2001 · AG
ETHANOL MEDIATED OSTEOPOROSIS AND INTERLEUKIN 6$86,119
R01 · FY2001 · AG
BIOMEDICAL RESEARCH TRAINING FOR VETERINARY SCIENTISTS$325,966
T32 · FY2000 · RR
ETHANOL MEDIATED OSTEOPOROSIS AND INTERLEUKIN 6$290,074
R01 · FY2000 · AG
AGING, GENE EXPRESSION AND OXIDATIVE STRESS$239,982
R01 · FY2000 · AG